Physician profile
Mark Greenberg
NPI 1982793931
$248.65
in general payments reported to CMS, 2019-2025
6 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.39 · 2020: $81.76 · 2021: $101.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $100.50 | 2021 | |
| Stimwave Technologies Incorporated | $63.43 | 2020 | |
| Pfizer INC. | $24.20 | 2019 | |
| Abbott Laboratories | $21.87 | 2019 | |
| Collegium Pharmaceutical, INC. | $20.32 | 2019 | |
| Medtronic USA, INC. | $18.33 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Greenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.